![Getlin Visser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Getlin Visser has a current job as the Chief Operating Officer at AMT Medical BV.
Postes actifs de Getlin Visser
Sociétés | Poste | Début |
---|---|---|
AMT Medical BV
![]() AMT Medical BV Medical SpecialtiesHealth Technology AMT Medical BV is a clinical stage medical device company based in Ede, Netherlands, that is developing a highly innovative and unique heart bypass system. The Elana heart bypass solution is designed to perform bypass surgery through small holes in the chest, without the need for open-heart surgery, split ribcage, heart-lung machine, or sutures. The innovative Elana procedure is applicable both in open chest and totally endoscopic procedure settings. The Dutch company collaborates with the UMC Utrecht, the St. Antonius Hospital Nieuwegein, and the German Heart Center/Charité in Berlin to develop a new improved way of performing heart bypasses. The company aims to improve the quality of life of millions of patients and their loved ones by minimizing long recovery times and serious complications. The company was founded by Rutger Tulleken, who has been the CEO since incorporation. | Directeur des opérations | 01/03/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
AMT Medical BV
![]() AMT Medical BV Medical SpecialtiesHealth Technology AMT Medical BV is a clinical stage medical device company based in Ede, Netherlands, that is developing a highly innovative and unique heart bypass system. The Elana heart bypass solution is designed to perform bypass surgery through small holes in the chest, without the need for open-heart surgery, split ribcage, heart-lung machine, or sutures. The innovative Elana procedure is applicable both in open chest and totally endoscopic procedure settings. The Dutch company collaborates with the UMC Utrecht, the St. Antonius Hospital Nieuwegein, and the German Heart Center/Charité in Berlin to develop a new improved way of performing heart bypasses. The company aims to improve the quality of life of millions of patients and their loved ones by minimizing long recovery times and serious complications. The company was founded by Rutger Tulleken, who has been the CEO since incorporation. | Health Technology |